Given the central pathogenic role of IL-6 in AP, both clinical and experimental studies suggest that targeting the IL-6 signaling pathwayparticularly its trans-signaling armmay represent a promising therapeutic approach
Semaglutide, with its impressive results in weight reduction, has become a sought-after treatment
Nakayama K, Tagawa R, Saito Y, Sanbongi C
Semaglutide is a GLP-1 receptor agonist that works at the hormonal level to reduce appetite, slow digestion, and quiet the constant mental negotiation around food
For superoxide anion, the main ROS, a first line of defense is represented by the enzyme superoxide dismutase, localized in the mitochondrial matrix